{"id":"NCT00484419","sponsor":"Daiichi Sankyo","briefTitle":"Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin","officialTitle":"Effects of Colesevelam HCl, AvandiaÂ® (Rosiglitazone Maleate), or JanuviaTM (Sitagliptin) on Glycemic Parameters and Lipid Profiles in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Monotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-05","primaryCompletion":"2008-04","completion":"2008-04","firstPosted":"2007-06-08","resultsPosted":"2009-06-17","lastUpdate":"2016-10-04"},"enrollment":169,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes","Hyperlipidemia"],"interventions":[{"type":"DRUG","name":"Colesevelam HCl","otherNames":[]},{"type":"DRUG","name":"rosiglitazone maleate","otherNames":[]},{"type":"DRUG","name":"sitagliptin phosphate","otherNames":[]}],"arms":[{"label":"colesevelam","type":"EXPERIMENTAL"},{"label":"rosiglitazone","type":"ACTIVE_COMPARATOR"},{"label":"sitagliptin","type":"ACTIVE_COMPARATOR"}],"summary":"A 16 week open-label study with subjects receiving background metformin monotherapy. 150 subjects randomized 1:1:1 to receive 1 of the following: open-label colesevelam HCl, open label rosiglitazone, or open-label sitagliptin.","primaryOutcome":{"measure":"Mean Percentage of Change in HbA1c From Week 0(Baseline) to Week 16 Endpoint","timeFrame":"16 weeks change = week 16 - week 0.","effectByArm":[{"arm":"Colesevelam","deltaMin":-0.31,"sd":0.898},{"arm":"Rosiglitazone","deltaMin":-0.65,"sd":0.836},{"arm":"Sitagliptin","deltaMin":-0.56,"sd":1.044}],"pValues":[{"comp":"OG000","p":"0.0234"},{"comp":"OG001","p":"<0.0001"},{"comp":"OG002","p":"0.0011"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":20,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":null,"commonTop":[]}}